1 citations
,
October 2018 in “International Journal of Research in Dermatology” In this study from a south Indian hospital, idiopathic hirsutism was the most common cause of hirsutism, with a significant portion of affected women also displaying features of metabolic syndrome.
1 citations
,
January 2017 in “International journal of women's health and reproduction sciences” This report discusses electroacupuncture as a complementary treatment for PCOS and suggests it may improve symptoms by enhancing ovulation and reducing testosterone and LH levels, but does not present new clinical results.
1 citations
,
October 2016 in “The American Journal of Gastroenterology” This case report highlights that celiac disease may cause levothyroxine malabsorption in patients with Hashimoto's thyroiditis, and a gluten-free diet can lead to improvement in thyroid hormone absorption.
1 citations
,
January 2016 in “Journal of Biosciences and Medicines” This study found that the ACTH/MC2R system is important for hair cycle regulation, with deficiencies in MC2R leading to altered hair growth phases in mice.
1 citations
,
October 2014 in “Journal of the American Geriatrics Society” This report describes a case of a 75-year-old woman whose diagnosis of hypopituitarism led to significant weight gain and improved physical function with treatment, highlighting the potential for overcoming frailty when investigating underlying causes in elderly patients.
1 citations
,
October 2013 in “Journal of Postgraduate Medical Institute” This study reported that Metformin effectively improved menstrual irregularities, LH:FSH ratio, and serum testosterone in women with PCOS, but did not alleviate hyperandrogenism symptoms.
1 citations
,
January 2011 Thorough evaluation and lab tests are crucial for understanding hair loss causes.
1 citations
,
January 2011 in “Journal of Human Reproductive Sciences” Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.
1 citations
,
May 2007 in “PubMed” This case study of a subfertile couple highlighted the importance of considering haemochromatosis, particularly involving the C282Y mutation of the HFE gene, in patients with endocrine disorders linked to hypogonadism.
This article provides physician associates with an evidence-based approach to diagnosing and treating alopecia, focusing on recognizing patterns, identifying triggers, and applying targeted interventions to improve patient outcomes in hair loss.
August 2026 in “Journal of Ayurveda and Integrated Medical Sciences” This case study of a 43-year-old woman with primary hypothyroidism found that an integrated Ayurvedic treatment over 20 weeks led to normalized thyroid function and relief of hypothyroid symptoms, highlighting Ayurvedic therapy's potential role in managing the condition.
August 2026 in “LUMEN ET VIRTUS” This study review reports that alopecia areata is often associated with autoimmune thyroid diseases like Hashimoto thyroiditis, suggesting targeted thyroid screening based on symptoms and risk factors may improve detection while minimizing unnecessary tests.
June 2026 in “kerbala journal of pharmaceutical sciences” In this case-control study, individuals with alopecia areata showed significantly elevated levels of inflammatory markers IL-4, IFN-γ, and CRP, as well as reduced serum Folate and Ferritin, suggesting the condition's multifactorial pathophysiology involves immune activation, systemic inflammation, and micronutrient deficiencies.
June 2026 in “International Journal for Research in Applied Science and Engineering Technology” This study formulated and evaluated a polyherbal hair growth oil using plants like Amla and Neem. The oil showed desirable physicochemical properties, stability, safety, and potential effectiveness, representing a promising natural alternative to synthetic hair care products for promoting healthy hair and scalp protection.
May 2026 in “Carbohydrate Polymer Technologies and Applications” This study found that the carbohydrate-based excipient β-cyclodextrin forms a stable inclusion complex with the active ingredient of Minoxicapil®, potentially enhancing its formulation for hair-loss treatment, and in vitro assays suggest improved proliferation of DPC cells, supporting its use in topical treatments.
April 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study utilized computational approaches to screen natural compounds targeting a non-androgen pathway involving PIEZO1 and MLCK for treating androgenetic alopecia, identifying several potential candidates for further validation but making no clinical claims.
April 2026 in “Global Journal of Health Science” This study observed that patients with hypothyroidism-associated hair loss commonly have deficiencies in several vitamins and minerals, suggesting that these deficiencies may be linked to their condition.
This study found no significant differences in thyrotropin levels among patients with different types of nonscarring alopecia, though racial differences were observed in alopecia areata and telogen effluvium.
March 2026 in “Brazilian Journal of Animal and Environmental Research” This study observed that deslorelin acetate implants reduced sexual activity and improved coat quality in a German Spitz dog with alopecia X, suggesting its potential as a less invasive and reversible treatment for managing reproductive function and this dermatopathy.
March 2026 in “Indian journal of veterinary and animal sciences research.” This case study found that treating a dog with primary hypothyroidism using oral levothyroxine sodium led to significant clinical improvement within six weeks.
March 2026 in “Physical Education Health and Social Sciences” In this randomized controlled trial, combining cinnamon and inositol led to significant improvements in metabolic and hormonal parameters, such as reduced LH, testosterone, fasting glucose, and ovarian ultrasound scores, in overweight women with PCOS, indicating superior benefits over either supplement alone.
March 2026 in “Journal of obstetrics and gynaecology research” In this study, Ark-e-Kasni was found to alleviate PCOS symptoms in rats by restoring hormonal levels, improving insulin sensitivity, and reducing inflammation and cystic follicles, suggesting its therapeutic potential via diverse molecular mechanisms.
January 2026 in “International Journal of Women s Health” This study found that a nomogram prediction model based on clinical characteristics, bone metabolism, and ovarian function can effectively predict the treatment response to long-acting GnRHa in girls with idiopathic central precocious puberty.
January 2026 in “Journal of Clinical Case Studies” This article discusses the potential of copper tripeptide (GHK-Cu) to support collagen synthesis and antioxidant activity in the context of androgenetic alopecia but reports no clinical results.
December 2025 in “Journal of Integrated Standardized Homoeopathy” This case report describes the use of individualized homoeopathic treatment and dietary modifications to manage hypothyroidism in a 23-year-old woman, resulting in symptom improvement and normalized TSH levels after tapering off levothyroxine.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers highlighted the potential of herbal hair oils made from rosemary (Rosmarinus officinalis) and black sesame (Sesamum indicum) as safe and effective alternatives to synthetic products, citing their antioxidant, anti-inflammatory, and nourishing properties that support scalp health and hair quality.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights the potential of herbal hair oil prepared with rosemary and black sesame for scalp health, hair strength, and appearance, emphasizing their antioxidant and nourishing benefits as a natural alternative to chemical formulations.
October 2025 in “Diseases” This study reports that women with hair loss had significantly lower levels of several biomarkers, including hemoglobin, iron, copper, selenium, vitamin D, vitamin B12, folate, and thyroid hormones, compared to healthy controls.
September 2025 in “Reproductive health of woman” This study found that in women with polycystic ovary syndrome, taking metformin for three months significantly reduced serum levels of luteinizing hormone, follicle-stimulating hormone, and testosterone, suggesting a beneficial effect on managing hyperandrogenism.
September 2025 in “Scientific periodicals of Ukraine” This study found that a 3-month treatment with metformin significantly reduced serum luteinizing hormone, FSH, and testosterone concentrations in women with PCOS.